Editorial: HLA-DR monitoring in the intensive care unit-More than a tool for the scientist in the laboratory?

Critical Care Medicine

Volumn 37, Issue 10, 2009, Pages 2849-2850

  Flohé, Sascha ^a   Scholz, Martin ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

HLA DR; Immune monitoring; Interferon gamma; Sepsis; Trauma

Indexed keywords

CYTOKINE; HLA DR ANTIGEN; IMMUNOSTIMULATING AGENT;

CRITICALLY ILL PATIENT; CYTOKINE PRODUCTION; EDITORIAL; IMMUNOPATHOLOGY; INTENSIVE CARE UNIT; LABORATORY TEST; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SEPSIS; ANTIGEN PRESENTING CELL; BACTERIAL INFECTION; BLOOD; CROSS INFECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MONITORING; MONOCYTE; MORTALITY; NOTE; PREDICTION AND FORECASTING; SEPTIC SHOCK; STATISTICS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANTIGEN-PRESENTING CELLS; BACTERIAL INFECTIONS; CROSS INFECTION; HLA-DR ANTIGENS; HUMANS; IMMUNE TOLERANCE; INTENSIVE CARE UNITS; MONITORING, PHYSIOLOGIC; MONOCYTES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SHOCK, SEPTIC; STATISTICS AS TOPIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 70349678322     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181ad7ac9     Document Type: Editorial

References (11)

1. Ditschkowsk M, Kreuzfelder E, Rebmann V, et al: HLA-DR expression and soluble HLA-DR levels in septic patients after trauma. Ann Surg 1999; 229:246-254
2. Wakefield CH, Carey PD, Foulds S, et al: Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery. Br J Surg 1993; 80:205-209
3. Monneret G, Lepape A, Voirin N, et al: Persisting low monocyte human leukocyte antigen- DR expression predicts mortality in septic patients. Intensive Care Med 2006; 32: 1175-1183
4. Hershman MJ, Cheadle WG, Wellhausen SR, et al: Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 1990; 77:204-207
5. Venet F, Tissot S, Debard AL, et al: Decreased monocyte human leukocyte antigen-DR expression after severe burn injury: Correlation with severity and secondary septic shock. Crit Care Med 2007; 35:1910-1917
6. Doecke WD, Randow F, Syrbe U, et al: Monocyte deactivation in septic patients: Restoration by IFN-gamma treatment. Nat Med 1997; 3:678-681
7. Flohé S, Lendemans S, Selbach C, et al: Effect of granulocyte-macrophage colonystimulating factor on the immune response of circulating monocytes after severe trauma. Crit Care Med 2003; 31:2462-2469
8. Nierhaus A, Montag B, Timmler N, et al: Reversal of immunoparalysis by recombinant human granulocyte-macrophage colonystimulating factor in patients with severe sepsis. Intensive Care Med 2003; 29:646-651
9. Lukaszewicz A-C, Grienay M, Resche-Rigon M, et al: Monocytic HLA-DR expression in intensive care patients: Interest for prognosis and secondary infection prediction. Crit Care Med 2009; 37:2746-2752
10. Polk HC, Cheadle WG, Livingston DH, et al: A randomized prospective clinical trial to determine the efficacy of interferon-gamma in severely injured patients. Am J Surg 1992; 163:191-196
11. Dries DJ, Jurkovich GJ, Maier RV, et al: Effect of interferon gamma on infection-related death in patients with severe injuries. A randomized, double-blind, placebo-controlled trial. Arch Surg 1994; 129:1031-1041